Skip to content
Sulfapyridine
Sulfapyridine is a small molecule pharmaceutical. Sulfapyridine was first approved as Sulfapyridine on 1982-01-01. It is used to treat bullous pemphigoid, dermatitis herpetiformis, and pyoderma gangrenosum in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
skin and connective tissue diseasesD017437
immune system diseasesD007154
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Sulfapyridine
Tradename
Company
Number
Date
Products
SULFAPYRIDINEEli LillyN-000159 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
bullous pemphigoidEFO_0007187D010391L12
dermatitis herpetiformis—D003874L13.0
pyoderma gangrenosumEFO_0006835D017511L88
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01E: Sulfonamides and trimethoprim antibacterials for systemic use
— J01EB: Short-acting sulfonamides
— J01EB04: Sulfapyridine
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameSULFAPYRIDINE
INNsulfapyridine
Description
Sulfapyridine is a sulfonamide consisting of pyridine with a 4-aminobenzenesulfonamido group at the 2-position. It has a role as an antiinfective agent, a dermatologic drug, a xenobiotic, an environmental contaminant and a drug allergen. It is a member of pyridines, a sulfonamide, a substituted aniline and a sulfonamide antibiotic. It is functionally related to a sulfanilamide.
Classification
Small molecule
Drug classantimicrobials (sulfonamides derivatives)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1
Identifiers
PDB—
CAS-ID144-83-2
RxCUI10188
ChEMBL IDCHEMBL700
ChEBI ID132842
PubChem CID5336
DrugBankDB00891
UNII IDY5V2N1KE8U (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 1,832 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details